Mometasone Furoate–Induced Iatrogenic Cushing’s Syndrome and Secondary Adrenal Insufficiency: A Case Report
Intranasal corticosteroids (INCS) are widely used to treat allergic rhinitis and nasal obstruction. While their safety profile is generally well established, both local and systemic side effects can occur. While it is well-known that a chronic exposure to systemic glucocorticoid treatment could dete...
Saved in:
| Main Authors: | Anna Insalaco, Sara Vandelli, Simona F. Madeo, Patrizia Bruzzi, Viola Trevisani, Barbara Predieri, Laura Lucaccioni, Lorenzo Iughetti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Case Reports in Pediatrics |
| Online Access: | http://dx.doi.org/10.1155/crpe/6109378 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EFFICACY AND SAFETY OF USING MOMETASONE FUROATE IN CHILDREN WITH ATOPIC DERMATITIS
by: A.Yu. Tomilova, et al.
Published: (2009-08-01) -
Suppression of cytokine release by fluticasone furoate vs. mometasone furoate in human nasal tissue ex-vivo.
by: Nan Zhang, et al.
Published: (2014-01-01) -
Efficacy and safety of combined loratadine and mometasone furoate therapy in allergic rhinitis patients
by: Hui Yong, et al.
Published: (2025-06-01) -
In perennial allergic rhinitis, RQLQ is improved similarly by Azelastine 0.15 and mometasone furoate
by: Jean Bousquet, MD, et al.
Published: (2025-01-01) -
Incorporation of Mometasone Furoate into a Cyclodextrin Metal-Organic Framework to Optimize Nasal Administration
by: Jie Li, et al.
Published: (2025-06-01)